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Abstract 
Visceral leishmaniasis (VL) is a widely spread zoonotic disease. In Brazil the disease is caused by Leishmania (Leishmania) 
infantum chagasi. Peridomestic sandflies acquire the etiological agent by feeding on blood of infected reservoir animals, such 
as dogs or wildlife. The disease is endemic in Brazil and epidemic foci have been reported in densely populated cities all over 
the country. Many clinical features of Leishmania infection are related to the host-parasite relationship, and many candidate 
virulence factors in parasites that cause VL have been studied such as A2 genes. The A2 gene was first isolated in 1994 and then 
in 2005 three new alleles were described in Leishmania (Leishmania) infantum. In the present study we amplified by polymerase 
chain reaction (PCR) and sequenced the A2 gene from the genome of a clonal population of L. (L.) infantum chagasi VL 
parasites. The L. (L.) infantum chagasi A2 gene was amplified, cloned, and sequenced in. The amplified fragment showed 
approximately 90% similarity with another A2 allele amplified in Leishmania (Leishmania) donovani and in L. (L.) infantum 
described in literature. However, nucleotide translation shows differences in protein amino acid sequence, which may be 
essential to determine the variability of A2 genes in the species of the L. (L.) donovani complex and represents an additional tool 
to help understanding the role this gene family may have in establishing virulence and immunity in visceral leishmaniasis. This 
knowledge is important for the development of more accurate diagnostic tests and effective tools for disease control.
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Resumo
A leishmaniose visceral (LV) é uma zoonose amplamente disseminada, causada no Brasil pela Leishmania (Leishmania) 
infantum chagasi. Flebotomíneos vetores adquirem o agente etiológico, alimentando-se do sangue de animais contaminados, 
como cachorros ou animais selvagens. A doença é endêmica no Brasil, e focos de epidemia são relatados em cidades densamente 
povoadas por todo o país. Muitas manifestações clínicas relacionadas à infecção por Leishmania estão ligadas à relação parasito-
hospedeiro, e vários possíveis fatores de virulência dos parasitas, que causam a LV, são alvos de estudo, tais como os genes 
A2. O gene A2 foi isolado pela primeira vez em 1994 e, em seguida, em 2005, três novos alelos foram descritos em Leishmania 
(Leishmania) infantum. No presente estudo, um fragmento do gene A2 de uma população clonal de L. (L.) infantum chagasi 
foi amplificado por PCR e sua sequência de nucleotídeos determinada. O fragmento mostrou 90% de similaridade com alelos 
do gene A2 de Leishmania (Leishmania) donovani e de L. (L.) infantum, descritos na literatura. Entretanto, a tradução da 
sequência de nucleotídeos mostra diferenças na sequência de aminoácidos da proteína, que podem ser essenciais em determinar 
a variabilidade do gene A2 em espécies do complexo L. (L.) donovani e representa uma ferramenta adicional na compreenssão 
do papel dessa família de genes na virulência e imunidade da leishmaniose visceral. O conhecimento dessa variação é importante 
para o desenvolvimento de testes diagnósticos mais precisos e ferramentas mais eficazes no controle da doença.
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Introduction
Visceral leishmaniasis (VL) is widespread in tropical and 
subtropical areas of Latin America, Europe, Africa and Asia. 
In the New World, the disease is caused by L. (L.) infantum 
chagasi being the sandfly Lutzomyia longipalpis its main vector 
(MELO et al., 2009). Peridomestic sandflies acquire the etiological 
agent L. (L.) infantum chagasi – which some authors consider to be 
the same species as L. (L.) infantum (MAURÍCIO et al., 1999) –, 
by feeding on blood of infected reservoir animals such as dogs or 
wildlife. Infected sandflies represent great danger to surrounding 
human populations because transmission to non-infected hosts can 
cause severe disease that may be fatal if not promptly treated (TESH, 
1995). In Brazil, canine visceral leishmaniasis (CVL) has become 
a serious public health problem due to the growing number of 
urban cases and new foci (SILVA et al., 2001; GONTIJO; MELO, 
2004; NASCIMENTO et al., 2008). From the epidemiological 
standing point, CVL is more important than human disease 
due to its higher prevalence and greater number of parasites in 
the skin, which can favors vector infection (TRAVI et al., 2001; 
VERÇOSA et al., 2008). 
Clinical signs in CVL depend on the immune response, which 
is directly associated to the host’s genetic factors. Humoral and 
cellular immune response are involved, and severity and clinical 
manifestations depends on a balance between these two systems, 
parasite tropism and virulence (CIARAMELLA et al., 1997; 
HONORE et al., 1998; GARIN et al., 2001). Among candidate 
virulence factors in parasites that cause VL are the A2 genes 
(ZHANG; MATLASHEWSKI, 1997, 2001).
A2 genes consist of a family of genes that are abundantly 
transcribed and translated during the amastigote phase in leishmanias 
from the Donovani complex whereas their messenger RNA and 
protein are not present in the promastigote phase (CHAREST; 
MATLASHEWSKI, 1994; GHEDIN et al., 1997; ZHANG; 
MATLASHEWSKI, 2001; FARAHMAND et al., 2008). The A2 
genes of L. (L.) donovani are composed predominantly of a sequence 
encoding 10 amino acids that may be repeated 40 to 90 times 
depending on each specific gene (CHAREST; MATLASHEWSKI, 
1994; GHOSH; ZHANG; MATLASHEWSKI, 2001). 
A2 genes share similarities with the S antigen expressed by 
Plasmodium falciparum (CHAREST; MATLASHEWSKI, 1994), 
and a possible role for the structure/functionality of A2 genes 
in the cutaneous or visceral tropism of Leishmania parasites in 
L. major and L. (L.) infantum has been studied and suggested 
(GHEDIN et al., 1997; ZHANG et al., 2003; GARIN et al., 
2005). Species that cause Old and New World VL, L. (L.) donovani, 
L. (L.) infantum, and L. (L.) infantum chagasi, and New World 
cutaneous leishmaniasis (CL), L. mexicana and L. amazonensis, 
have A2 genes in their chromosomes (GHEDIN et al., 1997). 
In L. major A2 is considered a pseudogene, and the introduction 
of L. (L.) donovani A2 gene in this species allowed its survival in 
visceral organs of mice (ZHANG et al., 2003). The gene was isolated 
and expressed for the first time in L. (L.) donovani (CHAREST; 
MATLASHEWSKI, 1994, ZHANG et al., 1996). In 2005, three 
new alleles were described in L. (L.) infantum (GARIN et al., 
2005). There is evidence showing that A2 are stress response 
proteins, important to L. (L.) donovani survival in visceral organs 
(McCALL; MATLASHEWSKI, 2010). Sera from humans and 
dogs naturally infected with L. (L.) infantum chagasi reacted in a 
serological assay using A2 recombinant proteins (GHEDIN et al., 
1997; CARVALHO et al., 2002). 
The present study describes an A2 allele found in a 
L. (L.) infantum chagasi strain, isolated from a dog with VL treated 
in the Veterinary Hospital of Universidade Estadual Paulista in the 
city of Jaboticabal, São Paulo, Southeastern Brazil. We amplified, 
cloned, and sequenced a 743 bp fragment. The amplified fragment 
showed approximately 90% similarity with another A2 allele 
amplified in L. (L.) donovani (CHAREST; MATLASHEWSKI, 
1994) and L. (L.) infantum (GARIN et al., 2005).
Material and Methods
1. L. (L.) infantum chagasi strain
A strain of L. (L.) infantum chagasi was isolated from a dog’s 
bone marrow sample from the town of Olympia, São Paulo. The 
animal was examined at the Veterinary Hospital of FCAV-UNESP, 
Jaboticabal, São Paulo, with clinical symptoms of CVL and the 
strain obtained was used to isolate the A2 gene. The parasites were 
maintained in RPMI-1640 medium (Sigma-Aldrich, St. Louis, 
USA) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS; Gibco, Canyon City, USA) at 25 °C and strain 
characterization was made by polymerase chain reaction (PCR) and 
restriction fragment length polymorfism (PCR-RFLP) technique 
(CORTES et al., 2004; ANDRADE et al., 2006).
2. DNA extraction
L. (L.) infantum chagasi genomic DNA extraction was adapted 
from a proteinase K extraction previously described (CLER et al., 
2006). Briefly, promastigotes from axenic culture were harvested 
and then resuspended in 350 µL of TE buffer (Tris 10 mM; EDTA 
1 mM, pH 8.0) and 20 µL of SDS 10%. Ten µL of proteinase K 
(10 µg.µL–1) were subsequently added, and microtubes were 
incubated for 36 hours at 37 °C. After incubation, DNA was 
extracted with a standard procedure (phenol/chloroform/isoamilic 
alcohol) (25:24:1) and DNA precipitation was done using NaCl/
ethanol procedure (SAMBROOK; FRITSCH; MANIATIS, 
2001). The extracted DNA was dissolved in 20 µL of sterile water. 
3. PCR 
Amplification of L. (L.) infantum chagasi DNA 
(50 ng) matrix was done using L2/R3 primers(5’-
T T G G C A A T G C G A G C G T C A C A G T C / 5 ’ -
CAACGCGTACGATAATGCCACA) that correspond to the 
5’ end position 16301 and 16603 of the reverse complementary 
strand of the AC010851 sequence, respectively (GARIN et al., 
2005). In addition to DNA, PCR was performed in a reaction 
mixture of 25 µL containing 2.5 µL PCR buffer 10× (200 mM 
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Tris-HCl, pH 8.4, 500 mM KCl), 3 mM MgCl2, 200 µM each 
dNTP (dTTP, dATP, dGTP, dCTP, Eppendorf ), 0.5 µM of each 
primer (Invitrogen, Carlsbad, USA) and 1 U recombinant Taq 
polymerase (Invitrogen, Carlsbad, USA). L2/R3-PCR conditions 
consisted of denaturation for 3 minutes at 94 °C, followed by 
35 amplifi cation cycles at 94 °C for 1 minute, 1 minute at 58 °C, 
1 minute at 72 °C, then one cycle at 72 °C for 5 minutes. A total 
of 5 µL of PCR product was electrophoresed in 1% agarose gel 
in the presence of ethidium bromide, and visualized under UV 
light. A 100 bp ladder (Invitrogen, Carlsbad, USA) was used as 
MW marker.
4. DNA libraries and sequencing
L2/R3-PCR products were purifi ed with GeneClean II 
(QbioGene, 1001-400, Carlsbad, USA). Th e insertion of PCR 
products into pGEM-T Easy Vector Systems (Promega, Madison, 
USA), transformation of Escherichia coli DH10B competent cells, 
and cloning were performed using a PCR Cloning Kit (Promega, 
Madison, USA) as described by the manufacturer. One hundred 
and ninety-two clones were obtained and two A2-containing 
clones identifi ed by sequencing. Th e plasmid DNA was extracted 
by alkaline lysis (SAMBROOK; FRITSCH; MANIATIS, 2001) 
and sequenced by the Sanger method with M13 forward and M13 
reverse (Promega, Madison, USA) pri mers set using the BigDye 
Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer 
Applied Biosystems, Courtaboeuf, France) on a ABI PRISM 3100 
DNA Analyzer (Applied Biosystems, Courtaboeuf, France). 
5. Sequence analysis
Sequences obtained were then analyzed by Phred (EWING 
et al., 1998) and cross-match (www.phrap.org) algorithms to 
perform base calling and trimming (Q ≥ 20) and to mask cloning 
vector bases, respectively. After this fi ltering process the sequences 
were submitted to BlastN and BlastX (ALTSCHUL et al., 1990) 
analysis against non-redundant (nr) NCBI database and the 
L. (L.) infantum v3.0a database (ftp://ftp.sanger.ac.uk/pub4/
pathogens/L_infantum/ DATASETS/). Th e L. (L.) infantum chagasi 
A2 nucleotide sequence was translated by dna2pep algorithm 
(http://www.cbs.dtu.dk/services/VirtualRibosome/) and  we took 
the same translation frame that was observed on BlastX best hits.
Global multiple alignments for DNA and protein sequences 
of the identifi ed L. (L.) infantum chagasi A2 gene, three A2 alleles 
from L. (L.) infantum (GARIN et al., 2005) and a L. (L.) donovani 
A2 gene (CHAREST; MATLASHEWSKI, 1994) were performed 
using ClustalW algorithm (THOMPSON; HIGGINS, 1994) 
and edited by BoxShade (http://www.ch.embnet.org/software/
BOX_form.html). Th e identity percentages among sequences on 
global multiple alignments were measured by the alistat algorithm 
included in the HMMER package (DURBIN et al., 1998).
6. GeneBank accession numbers
Th e accession number for the A2 gene isolated in L. (L.) infantum 
chagasi described in this study is [GenBank:GQ290460]; the 
accession numbers for L.(L.)infantum A2 alleles II, III, and IV 
are [GenBank:AY255807, GenBank: AY255808, and GenBank: 
AY255809], respectively (GARIN et al., 2005), and the accession 
number for L. (L.) donovani is [GenBank:S69693] (CHAREST; 
MATLASHEWSKI, 1994).
Results and Discussion
Direct sequencing and analyses of L2R3 PCR products from 
crude genomic DNA of L. (L.) infantum chagasi could not be 
performed. Th ese PCR products resolved in a pattern of multiple 
bands (Figure 1), and thus A2 sequence was obtained from clone 
libraries as described in Methods. 
An identical A2-gene sequence of 743 nucleotides was isolated 
in two clones from the genomic library of L. (L.) infantum chagasi. 
BlastN analysis of this new sequence and other four diff erent 
VL A2 alleles, against all annotated CDSs from L. (L.) infantum 
genome version 3.0a, showed gene LinJ22_V3.0670 as the best hit 
for all fi ve query sequences. Our sequence showed 95% similarity 
with this gene; alleles isolated from L. (L.) infantum showed 
97% (Type II), 91% (Type III), and 92% (Type IV) similarity; 
and L. (L.) donovani A2 allele showed 87% similarity (Table 1). 
However, considering only the coding region L. (L.) infantum 
chagasi has the same stop codon TAA present in L. (L.) infantum 
(Type II, III, and IV) (Figure 2), the sequence translated to 
an amino acid sequence has 342bp and is 98,9% identical to 
L. (L.) infantum (Type II) (Figure 3). 
Since the fi rst description of A2 gene, the existence of at least fi ve 
closely related genes (A2 series) has been investigated (CHAREST; 
MATLASHEWSKI, 1994; ZHANG; MATLASHEWSKI, 
2001). Zhang et al. (1996) described A2 as a multigene family, 
which expresses diff erent sizes of 10-amino acid repeats. Th ree 
diff erent A2-gene alleles in a genetically pure parasite clonal 
lineage (L. infantum MHOM/FR/92/LEM 2385 clone-1) were 
subsequently isolated, providing additional evidence of the 
existence of multiple A2 genes (GARIN et al., 2005) and a 
diff erent A2 sequence is here described in L. (L.) infantum chagasi. 
Allele types I, II, and III described in the pure clonal lineage 
Figure 1. PCR electrophoresis patterns. Electrophoretic pattern 
of PCR products obtained from L. (L.) infantum chagasi genomic 
DNA. Each slot corresponds to a single sample amplifi ed using the 
same PCR mix. Th e framed area corresponds to the expected sizes 
for the A2 gene.
v. 20, n. 1, jan.-mar. 2011 A novel A2 allele found in Leishmania (Leishmania) infantum chagasi 45
Figure 2. Multiple alignment of A2 nucleotide sequences from L. (L.) infantum (allele types II, III, and IV), L. (L.) donovani and 
L. (L.)  infantum chagasi.
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L. (L.) infantum MHOM/FR/92/LEM 2385 clone-1 diff er only 
in the number and arrangements of the repeated motifs at the 3’ 
end variable region of the gene (GARIN et al., 2005) and in all 
cases, only strains from the L. (L.) donovani complex causing VL 
in Old World were sequenced. 
In the present study, we used a clinical isolate of a L. (L.) infantum 
chagasi infected dog to identify and sequence an A2 gene copy, 
corroborating previous fi ndings that the A2 family of VL species 
is a multiple gene family. 
Th e present study evidenced a divergent A2 gene in the 
L. (L.) infantum chagasi strain when compared to the L. (L.) infantum 
and L. (L.) donovani A2 alleles fi rst identifi ed. A comparative analysis 
of the A2 gene isolated from L. (L.) donovani, three A2-gene alleles 
isolated from L. (L.) infantum (Type II, III, and IV), and the 
A2 gene isolated from L. (L.) infantum chagasi herein described 
showed that the 5’ ORF is highly preserved (Figure 2) in both 
nucleotide and amino acid sequences obtained by nucleotide 
sequence translated by dna2pep algorithm. At the protein level, 
the sequences aligned had an identity average of 93%, but this 
analysis showed few diff erences among the sequences that can cause 
great changes in protein function. Close to 170 and 200 positions 
of the alignment ruler (Figure 3) there is an alanine residue in 
L. (L.) infantum chagasi sequence instead of a serine residue present 
in the other A2 sequences analyzed. 
Table 1. BlastN analysis of diff erent A2 alleles. BlastN analysis of fi ve diff erent VL A2 alleles against all annotated CDSs in L. (L.) i nfantum 
genome version 3.0a. Th e LinJ22_V3.0670 gene was the best hit for all fi ve query sequences. Queries Li_II, Li_III, and Li_IV are L. (L.)  infantum 
A2 alleles described by Garin et al. (2005), and query L. donovani is the A2 gene from L. (L.) donovani described by Charest and Matlashewski 
(1994), and query L. chagasi is the V allele herein described.
Query id Subject id % identity Alignment 
length
q. start q. end s. start s. end e-value Bit
Li_II LinJ22_V3.0670 97 202 29 230 1 202 2,00E-97 353
Li_III LinJ22_V3.0670 91 274 29 302 1 253 1,00E-109 392
Li_IV LinJ22_V3.0670 92 340 29 368 1 319 1,00E-141 500
L_donovani LinJ22_V3.0670 87 574 29 590 1 556 1,00E-165 579
L_chagasi LinJ22_V3.0670 95 194 54 247 1 193 3,00E-85 313
(q.start: start of query sequence; q. end: end of query sequence; s. start: start of sequence; s.end: end of sequence).
Figure 3. Multiple alignments of A2 amino acid sequences (translated nucleotide sequences by dna2pep algorithm.) from L. (L.) infantum 
(allele types II, III, and IV), L. (L.) donovani and L. (L.) infantum chagasi.
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The L. (L.) donovani’s A2 protein shows immunogenicity. 
Significant protection against L. (L.) donovani and L. amazonensis 
infections associated with both humoral and cellular immune 
responses has been seen when using A2 as a recombinant 
protein or a DNA vaccine in BALB/c mice, and more recently 
in dogs (GHOSH; ZHANG; MATLASHEWSKI, 2001; 
COELHO et al., 2003; ZANIN et al., 2007; RESENDE et al., 
2008; FERNANDES et al., 2008). A recombinant L. (L.) tarentolae 
expressing the L. (L.) donovani-specific A2 protein used as a live 
vaccine against L. (L.) infantum infection in BALB/c mice has 
provided evidence of favorable immune response and significant 
levels of protective immunity against L. (L.) infantum infections 
(MIZBANI et al., 2009).
This study evidences that there are differences in nucleotide 
sequences, and possible in amino acid of A2 protein sequences, 
which can be essential to establish specific pathogenic pathways 
in Leishmania species. In two positions of the C-terminal region 
on the A2 protein multiple alignment, L. (L.) infantum chagasi 
has an alanine residue while the other A2 sequences have a serine 
residue. This change might cause changes in three-dimensional 
structure of the protein and consequently in its function. 
Phenotypic effects of the alteration are more drastic, according 
to the differences in the chemical nature of side chains of amino 
acid residues, the substitution of an amino acid hydrophilic by 
one amino acid with hydrophobic side chain of residue, as here 
described, can cause great changes in functional activity of the 
protein (NELSON; COX, 2006). Since multiple A2 sequences 
of varying lengths were observed in different VL isolates by our 
group and by others, our results may help to determine the 
variability of A2 genes in the species of the L. (L.) donovani 
complex and represents an additional tool to help us understand 
the role this family of genes may have in establishing virulence 
in visceral leishmaniasis. The exact function of A2 protein 
in Leishmania is still unknown (AZIZI et al., 2009). Gene 
silencing of A2 in L. (L.) donovani dramatically decreased 
its viability and pathogenicity in mammalian macrophages 
(ZHANG; MATLASHEWSKI, 1997). Overexpression of A2 
in L. major resulted in visceralization of infection (ZHANG; 
MATLASHEWSKI, 1997; GARIN et al. 2005) and A2 gene was 
the only virulence factor that was not found in non-pathogenic 
parasites to human L.(L.) tarentolae (AZIZI et al., 2009), 
further supporting A2 gene importance in the pathogenesis 
of leishmaniasis. In Brazil, visceral leishmaniasis is caused by 
L. (L.) infantum chagasi, and the evidenced differences among 
A2 genes in species are important to elucidate the role of this 
gene in VL, which is essential for the development of more 
accurate diagnostic tests and effective tools for disease control. 
Studies with southern blotting and protein expression are being 
conducted with A2 gene isolated in L. (L.) infantum chagasi to 
confirm and better understand the changes found.
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